Direct Medical Cost Inpatient ACS-STEMI at Sardjito Hospital 2017-2018

M. Fiqri Zulpadly, Anif Nur Artanti, Dian Eka Ermawati, Sholichah Rohmani, Heru Sasongko, Wisnu Kundarto


Cardiovascular disease is the main cause of human death worldwide. This disease is also a major burden in health financing, due to direct costs of treatment and hospitalization. One type of cardiovascular disease is Acute Coronary Syndrome (ACS). The incidence of ACS in Indonesia is still the highest with a prevalence rate of 7.2% and continues to increase every year. This study aimed to determine the average direct medical costs of new ACS-STEMI patients who are hospitalized at Dr. Sardjito Hospital Yogyakarta period 2017-2018 and the factors that influence the cost of the treatment statistically. This research was an observational study with a descriptive retrospective research design using data from medical records and the finance (accounting) department. The sampling technique used in this study was purposive sampling based on patients who met the inclusion criteria. A total of 495 patients matched the inclusion criteria and the average of the components of direct medical costs incurred by inpatients was IDR48,926,665 with an average length of stay of 5 days. Statistical test results showed that the categories of gender, age, and payment method were not significantly associated with the average total cost of care for ACS-STEMI patients (p>0.05). Meanwhile, the categories of length of stay and treatment regimen were significantly correlated to the average total cost of care for ACS-STEMI patients (p<0.05). The average total cost of new ACS-STEMI patients undergoing inpatient treatment amounted to IDR48,926,665 which was significantly influenced by the category of the length of hospitalization and therapeutic regimen.


acute coronary syndrome; cost; inpatient; STEMI

Full Text:



Andayani, T.M. (2013). Farmakoekonomi, Prinsip dan Metodologi. Yogyakarta: Bursa Ilmu.

Andrikopoulos, G., Terentes-Printzios, D., Tzeis, S., Vlachopoulos, C., Varounis, C., Nikas, N., Lekakis, J., Stakos, D., Lymperi, S., Symeonidis, D., Chrissos, D., Kyrpizidis, C., Alexopoulos, D., Zombolos, V., Foussas, S., Kranidis, A., Oikonomou, K., Vasilikos, V., Andronikos, P., Dermitzakis, A., Richter, D., Fragakis, N., Styliadis, I., Marvidis, S., Stefanadis, C., and Vardas, P., (2016). Epidemiological characteristics, management and early outcomes of acute coronary syndromes in Greece: The PHAETHON study. Hellenic J. Cardiol. 57(3): 157-166.

Asikin, M., Nuralamsyah, M., and Susaldi. (2016). Keperawatan Medikal Bedah Sistem Kardio Vaskular, Jakarta: Erlangga.

Aurelia, A., and Pujiyanti, E., (2017). Unit Cost and Cost Recovery Rate of In-Patients with Acute Coronary Syndrome in Hospital X, 2015. Journal Ekonomi Kesehatan Indonesia. 1(3): 132-137.

Carey, M.G. (2016). Acute Coronary Syndrome and ST Segment Monitoring. Critical Care Nursing Clinics. 28: 347–355.

Departemen of Health Human Service of USA. (2010). How to tobacco smoke cause disease the biology and behavioral basis for smoking. Atlanta: US Government Printing Office.

Garcia, M.M., Ortega, M.S., Arriaga, I.V., Lemus, E.H., Herrera, R.G., and Vallejo M. (2018). A systematic approach to analyze the social determinants of cardiovascular disease. PloS. ONE. 13(1): 1-25.

Hedayati, T., Yadav, N., and Khanagavi, J., (2017). Non–ST-Segment Acute Coronary Syndromes. Cardiology Clinics. 36(1). 37-52.

Indrawati, L. (2014). Hubungan Antara Pengetahuan, Sikap, Persepsi, Motivasi, Dukungan Keluarga dan Sumber Informasi Pasien Penyakit Jantung Koroner dengan Tindakan Pencegahan Sekunder Faktor Risiko (Studi Kasus Di RSPAD Gatot Soebroto Jakarta), Jurnal Ilmiah WIDYA 2(3):30-36.

Indonesian Ministry of Health, (2017). Penyakit Jantung Penyebab Kematian Tertinggi, Kemenkes Ingatkan CERDIK. diakses pada 29 Juli 2017

Makki, N., Brennan, T.M., and Girotra, S., (2015). Acute Coronary Syndrome. Journal of intensive care medicine. 30(4) 186-200.

Nafrialdi, N., Handini, N.M., Instiaty, I., and Wijaya, I.P. (2018). A cost-effectiveness and safety analysis of dual antiplatelet therapy comparing aspirin–clopidogrel to aspirin–ticagrelor in patients with acute coronary syndrome. Medical Journal of Indonesia. 27(4): 262-270.

Rihova, B., Parenica, J., Jarkovsky, J., miklik, R., Sulcova, A., Littnerova, S., Felsoci, M., Kala, P., and Spinar, J., (2013). Cardiology department hospitalization costs in patientswith acute heart failure vary according to the etiology ofthe acute heart failure: Data from the AHEAD Coreregistry 2005–2009. Cor et Vasa. 55(1): 7-14.

Tofler, G.H., Kopel, E., Klempfner, R., Eldar, M., Buckley, T., and Goldenberg, I. (2017). Triggers and timing of acute coronary syndrome. The American Journal of Cardiology. 119(10): 1560-1565.

Wong, W.D. (2014). Epidemiological studies of CHD and the evolution of preventive cardiology. Nature Reviews Cardiology. 11(5). 276-89.


  • There are currently no refbacks.